Key result
Red wine polyphenols show mechanistic cardiovascular promise, but clinical evidence remains confounded.
Why the study?
Does red wine or resveratrol provide greater cardiovascular benefits compared to white wine or alcohol?
Does red wine or resveratrol provide greater cardiovascular benefits compared to white wine or alcohol?
Mechanistic evidence for resveratrol supports the potential cardiovascular benefits of red wine, providing a rationale for prospective therapeutic trials.
No takes yet. Share an insight, caveat, or question.
Red wine intake should not be recommended for cardiovascular protection; leaves open resveratrol's role pending randomized trials.
Opie et al. (2007) conducted a review in Cardiovascular disease. Red wine and resveratrol vs. White wine or alcohol was evaluated. Red wine and its specific polyphenols, especially resveratrol, demonstrate potential cardiovascular benefits through various molecular mechanisms, though epidemiological evidence remains confounded.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: